Moreno, V., Martínez-Amores, B., Barriuso, J., Mezquita, L., Ibáñez de Cáceres, I., Ayuso, Á., . . . Belda-Iniesta, C. (2012). PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain. Value in Health, 15(7), A421. https://doi.org/10.1016/j.jval.2012.08.2111
Chicago Style (17th ed.) CitationMoreno, V., et al. "PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain." Value in Health 15, no. 7 (2012): A421. https://doi.org/10.1016/j.jval.2012.08.2111.
MLA (9th ed.) CitationMoreno, V., et al. "PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain." Value in Health, vol. 15, no. 7, 2012, p. A421, https://doi.org/10.1016/j.jval.2012.08.2111.